Braun Stacey Associates’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.4M Sell
255,550
-9,238
-3% -$992K 0.99% 31
2025
Q1
$26.7M Sell
264,788
-2,955
-1% -$298K 1.09% 29
2024
Q4
$23.9M Sell
267,743
-3,513
-1% -$314K 0.89% 41
2024
Q3
$22.7M Sell
271,256
-1,735
-0.6% -$145K 0.86% 51
2024
Q2
$21M Buy
+272,991
New +$21M 0.81% 52
2020
Q4
Sell
-336,282
Closed -$12.8M 131
2020
Q3
$12.8M Sell
336,282
-3,013
-0.9% -$115K 0.69% 74
2020
Q2
$11.9M Buy
339,295
+2,739
+0.8% +$96.2K 0.69% 76
2020
Q1
$11M Sell
336,556
-66,530
-17% -$2.17M 0.84% 56
2019
Q4
$18.2M Buy
403,086
+3,036
+0.8% +$137K 1.01% 34
2019
Q3
$16.3M Buy
400,050
+14,500
+4% +$590K 1.03% 39
2019
Q2
$16.6M Sell
385,550
-390
-0.1% -$16.8K 1.06% 33
2019
Q1
$14.8M Buy
385,940
+41,565
+12% +$1.6M 0.98% 46
2018
Q4
$12.2M Buy
344,375
+153,575
+80% +$5.43M 0.96% 46
2018
Q3
$7.35M Buy
190,800
+21,795
+13% +$839K 0.47% 91
2018
Q2
$5.53M Buy
169,005
+13,800
+9% +$451K 0.38% 97
2018
Q1
$4.24M Sell
155,205
-198,960
-56% -$5.44M 0.29% 100
2017
Q4
$8.78M Sell
354,165
-268,130
-43% -$6.65M 0.59% 85
2017
Q3
$18.2M Sell
622,295
-63,345
-9% -$1.85M 1.24% 15
2017
Q2
$19M Sell
685,640
-36,565
-5% -$1.01M 1.23% 17
2017
Q1
$18M Sell
722,205
-4,590
-0.6% -$114K 1.14% 26
2016
Q4
$15.7M Sell
726,795
-36,270
-5% -$785K 1.03% 33
2016
Q3
$18.2M Sell
763,065
-78,755
-9% -$1.87M 1.15% 20
2016
Q2
$19.7M Sell
841,820
-28,750
-3% -$672K 1.27% 10
2016
Q1
$16.4M Sell
870,570
-100,450
-10% -$1.89M 1.07% 34
2015
Q4
$17.9M Buy
971,020
+622,600
+179% +$11.5M 1.13% 27
2015
Q3
$5.72M Buy
348,420
+100,185
+40% +$1.64M 0.38% 97
2015
Q2
$4.39M Buy
248,235
+17,715
+8% +$314K 0.19% 122
2015
Q1
$4.09M Buy
230,520
+4,130
+2% +$73.3K 0.24% 101
2014
Q4
$3M Sell
226,390
-75,915
-25% -$1.01M 0.18% 100
2014
Q3
$3.57M Sell
302,305
-160,490
-35% -$1.9M 0.22% 103
2014
Q2
$5.91M Buy
+462,795
New +$5.91M 0.35% 99